SCHEMBL20204643

SCHEMBL20204643

O=C1CCN(C/C=C/CCCNS(=O)(=O)c2ccc(F)c(O)c2)C(=O)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
TBXA2R P21731 1/20 0.36
ALDH1A1 P00352 2/20 0.34
POLB P06746 3/20 0.34
LMNA P02545 3/20 0.34
USP2 O75604 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CCR1 P32246 2/20 0.33
KMT2A Q03164 2/20 0.33
HTR7 P34969 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
GLA P06280 1/20 0.33
DUT P33316 2/20 0.33
HTR2A P28223 1/20 0.33
HTR6 P50406 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20191009 0.83 DUT (0.48) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL20190782 0.83 DUT (0.45) ALDH1A1POLBLMNAHTTDUT
SCHEMBL20190780 0.83 DUT (0.45) ALDH1A1POLBLMNAHTTDUT
SCHEMBL20191007 0.83 DUT (0.48) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL21522649 0.73 DUT (0.57) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL21536632 0.73 DUT (0.53) ALDH1A1POLBLMNAHTTDUT
SCHEMBL20189322 0.73 DUT (0.57) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL21536079 0.67 DUT (0.52) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL20190448 0.67 DUT (0.49) CYP3A4CYP2D6CYP2C19ALDH1A1POLB
SCHEMBL20204683 0.66 DUT (0.44) ALDH1A1KMT2ADUT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098209-A1 AMINO SULFONYL COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2018-05-31 WO disclosed